MDPI Contact

MDPI AG
St. Alban-Anlage 66,
4052 Basel, Switzerland
Support contact
Tel. +41 61 683 77 34
Fax: +41 61 302 89 18

For more contact information, see here.

Advanced Search

You can use * to search for partial matches.

Search Results

1 article matched your search query. Search Parameters:
Authors = Philip R. Johnson

Matches by word:

PHILIP (378) , R (8428) , JOHNSON (409)

View options
order results:
result details:
results per page:
Articles per page View Sort by
Displaying article 1-50 on page 1 of 1.
Export citation of selected articles as:
Open AccessReview Emerging Vaccine Technologies
Vaccines 2015, 3(2), 429-447; doi:10.3390/vaccines3020429
Received: 24 December 2014 / Revised: 5 May 2015 / Accepted: 18 May 2015 / Published: 26 May 2015
Cited by 6 | Viewed by 1738 | PDF Full-text (319 KB) | HTML Full-text | XML Full-text
Abstract
Vaccination has proven to be an invaluable means of preventing infectious diseases by reducing both incidence of disease and mortality. However, vaccines have not been effectively developed for many diseases including HIV-1, hepatitis C virus (HCV), tuberculosis and malaria, among others. The emergence
[...] Read more.
Vaccination has proven to be an invaluable means of preventing infectious diseases by reducing both incidence of disease and mortality. However, vaccines have not been effectively developed for many diseases including HIV-1, hepatitis C virus (HCV), tuberculosis and malaria, among others. The emergence of new technologies with a growing understanding of host-pathogen interactions and immunity may lead to efficacious vaccines against pathogens, previously thought impossible. Full article
(This article belongs to the Special Issue Vaccine Vector)

Years

Subjects

Refine Subjects

Journals

Refine Journals

Article Types

Refine Types

Countries

Refine Countries
Back to Top